VHCOX | VSTSX | VHCOX / VSTSX | |
Total Expense Ratio | 0.43 | 0.01 | 4,300% |
Annual Report Gross Expense Ratio | 0.43 | 0.01 | 4,300% |
Fund Existence | 30 years | 9 years | - |
Gain YTD | 15.395 | 12.988 | 119% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.6B | 1.95T | 1% |
Annual Yield % from dividends | 0.59 | 1.17 | 50% |
Returns for 1 year | 6.24 | 15.66 | 40% |
Returns for 3 years | 49.89 | 80.43 | 62% |
Returns for 5 years | 35.01 | 96.74 | 36% |
Returns for 10 years | 93.40 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 68.82 | 0.69 | +1.02% |
Virtus LifeSci Biotech Products ETF | |||
FDVV | 55.63 | 0.31 | +0.56% |
Fidelity High Dividend ETF | |||
XBAP | 37.80 | 0.08 | +0.22% |
Innovator US Eq Acltd 9 Bfr ETFTM April | |||
LQTI | 20.37 | 0.03 | +0.14% |
FT Vest Investment Grade & Target Income ETF | |||
DIAX | 14.76 | -0.01 | -0.07% |
Nuveen DOW 30Sm Dynamic Overwrite Fund |